Literature DB >> 3191614

Differential expression of pepsinogen isozymogens in a patient with Barrett esophagus.

G Pals1, A W Eriksson, J C Pronk, R R Frants, E C Klinkenberg-Knol, A Bosma, B D Westerveld, R T Taggart, I M Samloff, S G Meuwissen.   

Abstract

The pepsinogen A (PGA) isozymogens in the gastric mucosa and Barrett epithelium of a female patient with Barrett esophagus were studied on different occasions during a 3-year period by electrophoretic analysis of in vivo steady-state pepsinogen in biopsies by activity staining in combination with variant specific monoclonal antibodies and of de novo synthesized pepsinogen by autoradiography. In Barrett epithelium only one (Pg3) or two (Pg3 and Pg5) primary PGA gene products were detected, whereas in gastric mucosal biopsies three (Pg3, Pg4 and Pg5) primary gene products were demonstrated on all occasions. These differences strongly suggest differential expression/activation of individual gene numbers in the PGA gene cluster in Barrett esophagus and are in line with the preneoplastic nature of this condition. The mechanism behind this deregulation is currently under investigation by cell biology and molecular genetic techniques.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191614     DOI: 10.1111/j.1399-0004.1988.tb02842.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

1.  Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.

Authors:  Tina Samuels; Craig Hoekzema; Jon Gould; Matthew Goldblatt; Matthew Frelich; Matthew Bosler; Sang-Hyuk Lee; Nikki Johnston
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-06-15       Impact factor: 1.547

2.  Microarray expression profile analysis of mRNAs and long non-coding RNAs in pulmonary tuberculosis with different traditional Chinese medicine syndromes.

Authors:  Ting-Ting Jiang; Li-Liang Wei; Li-Ying Shi; Zhong-Liang Chen; Chong Wang; Chang-Ming Liu; Zhong-Jie Li; Ji-Cheng Li
Journal:  BMC Complement Altern Med       Date:  2016-11-17       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.